NIVOAD Study: Non Invasive Ventilation in Obstructive Airways Diseases Study

NIVOAD Study: Non Invasive Ventilation duration in Obstructive Airways Diseases Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000037606

Enrollment

192

Registered

2005-07-25

Start date

2005-06-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

CPAP vs BiPAP The duration is unknown but it is estimated to be in the order of 120 minutes

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients presenting to participating EDs with moderate to severe exacerbations of obstructive airways disease and judged by the clinical staff as requiring NIV. Criteria for this judgement include RR >23, SaO2 <90% on room air or <93% on 15 lpm via Hudson mask or an inability to speak in sentences.

Exclusion criteria

Obtundation (to the point of being unable to cooperate or protect the airway), primary cause of respiratory failure other than asthma or COAD, untreated pneumothorax, endotracheal intubation and a decision to withhold or withdraw treatment made by the clinician in consultation with the patient or next of kin.

Outcome results